Does Delaware Medicaid cover GLP-1s for weight loss?

Delaware Medicaid covers GLP-1s for weight loss with prior authorization

Covers weight loss with prior authorization
By Iacob Pastina, Independent Researcher & Publisher
Reviewed & updated · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

As an adult, you can get Delaware Medicaid to cover a GLP-1 for weight loss only through prior authorization.

You must meet its BMI and other rules, and your records decide whether you qualify. Read the rule and its criteria.

  • Yesfor adult weight loss, if you meet its prior authorization rules
  • Oct 5, 2026when the rules we checked took effect
  • $69/molowest cash price in Delaware, at Embody

Which drugs Delaware Medicaid covers, and for what:

Wegovy pens, Zepbound, Foundayo
Weight loss, preferred
Wegovy tablets, Saxenda
Weight loss, after trials of two preferred drugs

We checked 2 official documents on October 15, 2026. This is information, not medical advice or a benefit decision.

What does a GLP-1 cost without insurance in Delaware?

15 programs that serve Delaware publish a complete monthly price, from $69 at Embody to $297 at Direct Meds GLP-1.

Programs that serve Delaware, lowest monthly price first

Some programs are affiliate partners, and we may earn a commission if you join through our link. Payment never moves a row. How we rank

8 more programs serve Delaware without one complete monthly price: AgelessRx, Breeze Meds, Collective, Maximus, Nu Image Medical, Oak Longevity, Ro and Sesame Care. Compare their terms in the price index.

We left out 13 programs whose service-area list has a caveat for Delaware or is incomplete, so confirm your address at intake.

A program that serves Delaware still decides whether to prescribe, and it does not take Medicaid. Most sell compounded semaglutide or tirzepatide, which is not FDA-approved. Check a compounded provider before you pay.

  • Lowest in Delaware$69/moAt Embody, the lowest complete monthly price among programs that serve Delaware.
  • National median$149/moThe median advertised recurring price across 11 compounded programs we track, a national benchmark, not a measured Delaware average.
  • National range$69 to $299The lowest and highest advertised recurring prices in that group.

What does Delaware Medicaid cover for GLP-1s?

Here is our summary of the Delaware Medicaid rules we checked, with their criteria and limits.

Delaware Medicaid covers GLP-1 medicines for weight loss with prior authorization, under its preferred drug list live October 5, 2026 and its GLP-1 weight-management criteria revised April 20, 2026. Delaware Medicaid prefers Wegovy and Wegovy HD pens, the Zepbound auto-injector and KwikPen, and Foundayo tablets; before non-preferred Wegovy tablets or Saxenda, you need trials of two preferred drugs. As an adult, you need a BMI of 30 or higher, or 27 to under 30 with a listed condition such as heart disease, high blood pressure, type 2 diabetes or moderate to severe sleep apnea, plus diet and activity changes. To renew, you need to keep at least 5% weight loss as an adult. On the same form, your prescriber can request treatment for MASH with F2 or F3 fibrosis through a liver specialist, or for heart-risk reduction at a BMI of 27 or higher. Delaware applies these state criteria to fee-for-service members; if you are in a managed-care plan, your plan uses its own criteria, so ask your plan before you rely on them. Delaware Medicaid or your plan still decides each request.

A drug on the preferred list is not covered for every use, so check the rule for yours. A weight-loss exclusion leaves diabetes and other medical requests to their own rules.

We checked Delaware Medicaid preferred drug list, live October 5, 2026 (obesity treatment agents) on October 15, 2026.

We checked Delaware Medicaid PA request: GLP-1 agonist for weight management, MASH or MACE prevention, revised April 20, 2026 on October 15, 2026.

What should you ask Delaware Medicaid before you pay?

Call your Medicaid plan, Medicare drug plan or private insurer with these questions, and keep the reference number for each call.

Before you pay cash, confirm:

  • Whether your plan covers your exact drug, form and dose for your diagnosis and age.
  • Whether you are in fee-for-service or a managed-care plan, and who handles your prior authorization.
  • Which records your prescriber must send with the request.
  • Which pharmacy can fill it, and your drug copay apart from any visit, lab or membership fees.
  • Whether paying cash affects your benefits.
  • If the plan says no, the reason in writing, how to ask for a review and the deadline on the notice.

An “insurance accepted” badge does not tell you your benefit, so ask your plan how its review works.

What paperwork does prior authorization need?

Your prescriber sends Delaware Medicaid a request with the records that show you meet the rule for your drug and diagnosis, and Delaware Medicaid decides.

What Delaware Medicaid's own criteria ask for, from the documents we read:

  • To renew as an adult, records showing you kept at least 5% weight loss.
  • For MASH with F2 or F3 fibrosis, a request through a liver specialist on the same form.

What your prescriber usually sends:

  • The condition the request relies on, as Delaware Medicaid names it: Wegovy pens, Zepbound, Foundayo for weight loss, preferred; Wegovy tablets, Saxenda for weight loss, after trials of two preferred drugs.
  • Your BMI, with the height and weight it comes from and the date your prescriber measured them.
  • Chart notes that document the condition, such as a sleep study for sleep apnea or the liver scarring stage for MASH, where the rule asks for them.
  • The exact drug, form and dose your prescriber requests, and whether you have diabetes, because some routes exclude it.
  • What you have tried already: diet and activity changes, and any earlier medicine the rule asks about.
  • For a renewal, your weight, refill and treatment records since the first approval.

Your prescriber works from these Delaware Medicaid documents:

Your prescriber's office files the request; you cannot file it yourself. If Delaware Medicaid says no, ask for the reason in writing, because the notice tells you how to ask for a review and by when.

How does Medicare cover GLP-1s in Delaware?

Medicare's GLP-1 Bridge follows federal rules in every state, so Delaware Medicaid's policy does not decide your Medicare benefit.

GLP-1 Bridge
If your weight-management prescription qualifies and Humana, CMS's central processor, approves it, your drug copay is $50 a month. That copay does not count toward your Part D out-of-pocket spending.
Regular Part D
Ask your drug plan whether it covers your exact medicine for your diagnosis. A plan denial does not by itself make you eligible for the Bridge. Our Medicare GLP-1 coverage guide goes drug by drug.

We checked CMS's Bridge guidance for Part D plans on September 26, 2026.

Who can help with coverage in Delaware?

Two free official services can help you, and we earn no commission from either.

Medicaid
If a managed-care plan runs your drug benefit, call the member-services number on your card for its criteria and a written decision. Delaware Medicaid & Medical Assistance
Medicare counseling
Your State Health Insurance Assistance Program (SHIP) explains a plan or notice for free. It does not approve a prescription. Delaware SHIP counseling

Questions about GLP-1 access in Delaware

Does Delaware Medicaid cover GLP-1 medication for weight loss?

Delaware Medicaid covers GLP-1 medicines for weight loss with prior authorization, under its preferred drug list live October 5, 2026 and its GLP-1 weight-management criteria revised April 20, 2026.

Delaware Medicaid prefers Wegovy and Wegovy HD pens, the Zepbound auto-injector and KwikPen, and Foundayo tablets; before non-preferred Wegovy tablets or Saxenda, you need trials of two preferred drugs. As an adult, you need a BMI of 30 or higher, or 27 to under 30 with a listed condition such as heart disease, high blood pressure, type 2 diabetes or moderate to severe sleep apnea, plus diet and activity changes. To renew, you need to keep at least 5% weight loss as an adult. On the same form, your prescriber can request treatment for MASH with F2 or F3 fibrosis through a liver specialist, or for heart-risk reduction at a BMI of 27 or higher. Delaware applies these state criteria to fee-for-service members; if you are in a managed-care plan, your plan uses its own criteria, so ask your plan before you rely on them. Delaware Medicaid or your plan still decides each request. Before you pay, confirm your exact drug, your diagnosis, any age rules and your plan's authorization steps.

Is Medicare GLP-1 coverage different in Delaware?

Yes.

Medicare's GLP-1 Bridge follows federal eligibility rules in every state, not Delaware Medicaid's policy. Your ordinary Part D coverage depends on your prescription and your drug plan, and the Bridge runs its own eligibility and authorization review.

Can I get GLP-1 medication delivered in Delaware?

Yes, from 23 online programs that publish a service area including Delaware.

At intake, confirm your address, the exact medication and any pharmacy limits, because a state listing does not guarantee you a prescription or a delivery date.

How much does GLP-1 treatment cost in Delaware?

Among programs that serve Delaware, the lowest complete monthly price we found is $69 at Embody.

Across the 11 compounded programs we track nationally, the median advertised recurring price is $149/mo, from $69 to $299. That national figure is not a measured Delaware average, insurance copay or quote for your dose.

Featured Partners

Affiliate partners we feature. We may earn a commission.

Embody

from $69/mo·Compounded

Gala

Current program options·Brand & Compounded

Check the medication, commitment and total price for your selected plan.

Bodybuilding Health+

$179/mo month-to-month·Compounded

Affiliate links, we earn a commission at no extra cost to you. These are featured partners, prioritized by our affiliate economics, not an editorial "best" ranking. Published scores have different evidence limits and do not establish better care. See the program comparison and scoring limitations.